ArticleThe Journal of allergy and clinical immunology2022

TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung.

Rinna Tei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.